No Data
Chromocell Announces Name Change to "Channel Therapeutics Corporation" and Provides Therapeutic Program Updates
Chromocell Therapeutics | 10-Q: Q3 2024 Earnings Report
Chromocell Unveils Its Injectable Depot Program Utilizing Peripheral Nerve Blocks For The Treatment Of Post-Operative Pain
Express News | Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain
Chromocell to Present at Upcoming Fall Investor Conferences
12 Health Care Stocks Moving In Thursday's After-Market Session
No Data
No Data
